A final column by journalist Ditte Giese, who died from breast cancer at age 48, has sparked renewed debate over Denmark’s breast cancer screening age limits and driven a surge in mammography requests at private clinics. Giese criticized the screening program’s 50-year age threshold before her death, urging younger women to seek private scans.
Ditte Giese’s Final Call Resonates
Two days before Danish cultural journalist and author Ditte Giese passed away, she wrote her last column in Politiken. It was a personal farewell that has since reignited a national conversation about breast cancer screening in Denmark and prompted far more women to request mammograms at private clinics.
Under the headline “Farvel, kære læsere,” Giese described her six-year battle with breast cancer, a disease that prevented her from reaching 50 or seeing her child leave home. But the column wasn’t just a goodbye. It was a sharp critique of Denmark’s breast screening program, which only becomes available to women at age 50.
Because Giese was well under 50 when her symptoms began, her cancer diagnosis was delayed by four years, according to her account. She finally received it only after insisting on a mammogram herself. She urged all her friends under 50, and by extension her readers, to get a mammogram privately.
Private Clinics See Spike in Demand
Since the column’s publication, TV 2 Kosmopol has contacted several private X-ray clinics in Copenhagen. All report a significant increase in inquiries from women under 50. The response suggests that Giese’s words struck a chord with many who feel excluded from the public screening system.
In fact, private clinics in Denmark have been playing an increasingly important role in reducing public waitlists. In 2023, they received nearly 250,000 referrals from regional authorities, a record high despite a 12% rate cut imposed through a rebate deal. Even as referral volumes fluctuated later in the year, the demand for private healthcare services has remained strong.
Why Denmark’s Screening Starts at 50
The debate over lowering the screening age is far from new. In Sweden, women are offered breast cancer screening from age 40 to 74. Denmark, however, limits the program to women aged 50 to 69.
It has been more than three years since the European Health Union recommended that member states expand their screening programs to include women from 45 to 74. Several citizen proposals have raised the issue in Denmark, with the most recent gathering over 50,000 signatures and requiring parliamentary review last summer.
Despite this, no decision has been made to change the age limit. Politicians are awaiting the results of a study by the Danish Health Authority, which is examining the pros and cons of expanding the program. The results are expected in 2026.
The Challenge of Screening Younger Women
Lowering the screening age is more complicated than it might seem. Ilse Vejborg, chief physician at the Department of Breast Examinations at Herlev and Gentofte Hospital and screening director for the Capital Region’s breast cancer program, explains that there are also downsides to lowering the threshold.
As women age, their breast tissue changes. Connective and glandular tissue decreases, especially after menopause, making fat tissue appear darker on a mammogram. This contrast makes it easier to detect cancerous lumps in older women.
In younger women, breast tissue is often denser. This can make it harder to spot cancer because the dense tissue can hide lumps, which appear lighter on mammograms. Vejborg points out that this creates a risk of false reassurance. The method is less reliable in younger women because tissue contrast is poorer.
At the same time, she emphasizes that many years of life can be saved if cancer or precancerous changes are detected early.
Half of Cases Fall Outside Screening Range
Around half of all breast cancer cases occur in women aged 50 to 69, according to Vejborg. That means the other half affects women who currently do not receive annual mammograms.
For this reason, the chief physician is open to expanding the age range. If it were up to her, screening should be offered from age 45 to 74.
Vejborg believes the upper age limit, in particular, should be raised. Many women live longer and have an average of seven more years when they turn 75. Meanwhile, breast cancer incidence rises markedly with age. So it makes sense to consider whether more women should be offered screening, she says.
However, Vejborg is skeptical about lowering the threshold to 40, as Sweden has done. According to her, there is no clear evidence that it would make a meaningful difference.
In Denmark, around 4,850 women are diagnosed with breast cancer each year. Approximately 1,050 women die from the disease annually. In the Capital Region, about 0.8 percent of women who participate in the screening program are found to have breast cancer or precancerous changes.
A Growing Role for Private Healthcare
Ditte Giese’s death on January 26, 2026, two days after her final column, has drawn renewed attention to delays and access issues within Denmark’s healthcare system, particularly for cancer patients. Her case is part of a broader pattern in which private clinics are increasingly filling gaps left by the public sector.
Referrals to private hospitals peaked in mid-2023 but dropped later in the year after the treatment guarantee was extended from 30 to 60 days on June 1, 2023. This change gave public hospitals more time to meet targets, easing some statistical pressure. Still, surgical activity in public hospitals rose by only 0.1 percent, well below the 3 percent target, even after regions received an additional 1.1 billion kroner to reduce wait times.
Wait times continued to rise by Easter 2024, according to data from the Danish Health Data Authority. Private clinics, many of which are smaller and physician-owned, have adapted more flexibly to fluctuating demand than larger chains. Their role in the healthcare system has grown significantly since the early 2000s, when the free hospital choice policy was introduced.
What Lies Ahead
The conversation Ditte Giese started in her final days is now forcing policymakers and health professionals to reconsider long-standing screening protocols. While the Danish Health Authority prepares its findings, thousands of women are not waiting. They are seeking answers, and peace of mind, from private providers.
Whether Denmark will follow Sweden’s lead and lower the screening age remains uncertain. What is clear is that Giese’s voice, even in her final words, continues to be heard.
Sources and References
The Danish Dream: Danish Healthcare Explained for Tourists & Expats
The Danish Dream: Best Private Hospitals in Denmark for Foreigners
TV2: Ditte Gieses sidste opsang kan mærkes på private klinikker
